Cormedix Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

Listing Results Cormedix Contact Number

Contact Us CorMedix Prevention of cardiac, renal and

3 hours ago Cormedix.com Show details

908-517-9500

Contact Us. CorMedix Inc. 300 Connell Drive. Suite 4200. Berkeley Heights, NJ. TEL +1 908-517-9500. FAX +1 908-375-8272. For Investors & Media: Dan Ferry.

Category: Contact SupportShow more

Home CorMedix Prevention of cardiac, renal and

5 hours ago Cormedix.com Show details

Defencath™ , an investigational drug product, is a novel, antimicrobial and antifungal solution being developed for the prevention of catheter-related bloodstream infections (“CRBSIs”) in patients with end-stage renal disease receiving hemodialysis through a central venous catheter. Defencath™, an investigational drug product, was

Category: Home PhoneShow more

CorMedix Crunchbase Company Profile & Funding

8 hours ago Crunchbase.com Show details

908-517-9500

Contact Email [email protected] Phone Number 908-517-9500. CorMedix Inc. is a specialty pharmaceutical company that develops and seeks to commercialize products for the treatment of cardiac, renal and infectious diseases. Specifically, our goal is to treat human disease by reducing commonly associated renal, cardiovascular, metabolic and

Founded: 2006
Founder: Antony Pfaffle

Category: Contact NumberShow more

FAQs CorMedix Prevention of cardiac, renal and

1 hours ago Cormedix.com Show details

212-828-8436

The contact information for VStock Transfer is 18 Lafayette Place, Woodmere, New York 11598, 212-828-8436. Q. When was CorMedix Inc. incorporated? CorMedix Inc. was founded in 2006 and is now based in Berkeley Heights, New Jersey.

Estimated Reading Time: 1 min

Category: Contact NumberShow more

CorMedix Inc. Relocates Corporate Headquarters CorMedix

1 hours ago Cormedix.com Show details

CorMedix Inc. Relocates Corporate Headquarters. Berkeley Heights, NJ – September 25, 2017 – CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced that it has relocated its corporate …

Estimated Reading Time: 4 mins

Category: Contact NumberShow more

CorMedix Company Profile Office Locations, Competitors

5 hours ago Craft.co Show details

CorMedix has 30 employees at their 1 location and $283.27 K in annual revenue in FY 2019. See insights on CorMedix including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.

Category: Contact NumberShow more

Www.fda.gov

1 hours ago Fda.gov Show details

021-5419 2021

The list should cover all FDA centers and include each FDA inspection ID number, DUNS number and reason for inspection. 2021-5419 2021-4237 2021-4478 2021-4566 2021-5420 ANDA 203976 2021-5421 K&L

Category: Contact NumberShow more

SEC

6 hours ago Sec.gov Show details

EX-10.1 2 ea120863-8kex101_cormedix.htm EXECUTIVE EMPLOYMENT AGREEMENT, DATED AND EFFECTIVE APRIL 17, 2020, BETWEEN CORMEDIX INC. AND JOHN L. ARMSTRONG. and provided that the Company can require Executive to work at the Company’s headquarters for a reasonable number of days per month. contact xxx; and

Category: Contact NumberShow more

CorMedix Inc. Announces Regulatory Update

9 hours ago Finance.yahoo.com Show details

CorMedix assumes no obligation and does not intend to update these forward-looking statements, except as required by law. Investor Contact: Dan Ferry. Managing Director. LifeSci Advisors. (617

Category: Contact NumberShow more

CorMedix Inc. Announces Contract Extension of Jack

2 hours ago Globenewswire.com Show details

CorMedix Inc. Announces Contract Extension of Jack Armstrong as Executive Vice President and Head of Technical Operations. April 23, 2020 08:15 ET Source: CorMedix, Inc. CorMedix, Inc. Berkeley

Category: Contact NumberShow more

Investors CorMedix Prevention of cardiac, renal and

6 hours ago Cormedix.com Show details

CorMedix Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. Currently, the Company is focused on developing its lead investigational drug product, Defencath™, a novel, antibacterial and antifungal solution designed to

Category: Contact NumberShow more

Khoso Baluch B2B Contact Database Provider Adapt.io

1 hours ago Adapt.io Show details

Find Khoso Baluch's accurate email address and contact/phone number in Adapt.io. Currently working as President and Chief Executive Officer at Cormedix Inc. in New jersey, United States.

Category: Contact SupportShow more

CorMedix Inc. – The Law Office of Frank R. Cruz

8 hours ago Frankcruzlaw.com Show details

If you purchased CorMedix securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 1999 Avenue of the Stars, Suite 1100, Los Angeles, California

Category: Contact NumberShow more

Investor FAQs

2 hours ago Cormedixwebmaster.wixsite.com Show details

A. CorMedix’s common stock is traded on the NYSE MKT under the ticker symbol CRMD. Q. What is the CUSIP number for CorMedix Inc.’s common stock? A. The CUSIP number for CorMedix’s common stock is 21900C118. Q. How can I purchase shares of CorMedix Inc. common stock? A. At this time, CorMedix does not have a direct purchase program.

Category: Contact NumberShow more

CorMedix : Faces DefenCath Resubmission Delays on Issues

2 hours ago Marketscreener.com Show details

October 12, 2021

Category: Contact NumberShow more

CorMedix Inc Number of Employees 20112021 CRMD

9 hours ago Macrotrends.net Show details

CorMedix Inc number of employees from 2011 to 2021. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Compare CRMD With Other Stocks. CorMedix Inc Annual Number of Employees. 2020.

Category: Contact NumberShow more

CORMEDIX ALERT: Bragar Eagel & Squire, P.C. Announces That

3 hours ago Au.finance.yahoo.com Show details

If you purchased or otherwise acquired CorMedix shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker, Melissa Fortunato, or Marion Passmore by email at …

Category: Contact NumberShow more

CRMD CorMedix Inc. • BioPharmCatalyst

5 hours ago Biopharmcatalyst.com Show details

BERKELEY HEIGHTS, N.J., July 28, 2021 (GLOBE NEWSWIRE) -- CorMedix Inc. (NASDAQ: CRMD ), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced that it will report its financial results for the second quarter ended June

Category: Contact NumberShow more

CRMD Company Profile for CORMEDIX INC. MSN Money

2 hours ago Msn.com Show details

CorMedix Inc. is a commercial pharmaceutical and medical device company. The Company in-licenses, develops and commercializes prophylactic and therapeutic products for the prevention and treatment

Category: Contact NumberShow more

CorMedix, Inc. (CRMD) Statistics & Valuation Metrics

9 hours ago Stockanalysis.com Show details

Share Statistics. CorMedix has 38.08 million shares outstanding. The number of shares has increased by 45.67% in one year.

Category: Contact NumberShow more

Roche Freedman Announces the Filing of a Class Action

7 hours ago Rochefreedman.com Show details

646-392-8842

If you are a shareholder who purchased CorMedix securities during the Expanded Class Period, you have until September 20, 2021 to ask the Court to appoint you as Lead Plaintiff for the class. To discuss this action and/or obtain a copy of the Complaint, contact Ivy T. Ngo at [email protected] or 646-392-8842. Those who inquire by e-mail

Category: Contact NumberShow more

Bragar Eagel & Squire, P.C. Reminds Investors That Class

9 hours ago Finance.yahoo.com Show details

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Tarena, Orphazyme, DiDi, and CorMedix and Encourages Investors to Contact the Firm

1. Author: Bragar Eagel & Squire

Category: Contact NumberShow more

Bragar Eagel & Squire, P.C. Reminds Investors That Class

2 hours ago Ca.finance.yahoo.com Show details

Then on March 13, 2021, CorMedix announced that “[b]ased on our analyses, we have concluded that additional process qualification will be needed with subsequent validation to address the deficiencies identified by FDA.” On this news, CorMedix’s stock price fell $1.51 per share, or 19.97%, to close at $6.05 per share on May 14, 2021.

1. Author: Bragar Eagel & Squire

Category: Contact NumberShow more

CorMedix CEO retires; CFO to serve in interim role during

9 hours ago Roi-nj.com Show details

CorMedix Inc., a Berkeley Heights-based biopharmaceutical company, announced a number of leadership changes this week, including the retirement of its CEO. The company, which focuses on therapeutic products for infectious and inflammatory diseases, said CEO Khoso Baluch is retiring, and has also resigned from the board of directors. In addition, John …

Category: Contact NumberShow more

Pomerantz Law Firm Reminds Shareholders with Losses on

3 hours ago Law.com Show details

888.476.6529

To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their

Category: Contact NumberShow more

CorMedix Inc. (CRMD) Is Another Fantastic Bargain Stock

4 hours ago Marketingsentinel.com Show details

CorMedix Inc. (NASDAQ:CRMD)’s Major holders. Insiders own 1.72% of the company shares, while shares held by institutions stand at 28.62% with a share float percentage of 29.12%. Investors are also buoyed by the number of investors in a company, with CorMedix Inc. having a total of 113 institutions that hold shares in the company.

Category: Contact NumberShow more

Pomerantz Law Firm Announces the Filing of a Class Action

3 hours ago Law.com Show details

888.476.6529

To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their

Category: Contact NumberShow more

CorMedix Inc. Announces Regulatory Update

2 hours ago Globenewswire.com Show details

CorMedix assumes no obligation and does not intend to update these forward-looking statements, except as required by law. Investor Contact: Dan Ferry Managing Director LifeSci Advisors

Category: Contact NumberShow more

What Do Analysts Say About CorMedix Inc. (CRMD)? – The

1 hours ago Baxterreport.com Show details

The total number of common shares currently owned by the public is 38.08 million. CRMD does have institutional investors; and they hold 29.20% of the stock. CorMedix Inc. – Insider Activity and Holdings. Moreover, the latest SEC filings also revealed that stock came across 1 new insider purchases involving 15,000 shares.

Category: Contact NumberShow more

Roche Freedman Announces the Filing of a Class Action

2 hours ago Techtodaynewspaper.com Show details

646-392-8842

If you are a shareholder who purchased CorMedix securities during the Expanded Class Period, you have until September 20, 2021 to ask the Court to appoint you as Lead Plaintiff for the class. To discuss this action and/or obtain a copy of the Complaint, contact Ivy T. Ngo at [email protected] or 646-392-8842.

Category: Contact NumberShow more

Bragar Eagel & Squire, P.C. Reminds Investors That Class

2 hours ago Ca.finance.yahoo.com Show details

CorMedix informed investors that the “FDA noted concerns at the third-party manufacturing facility after a review of records requested by FDA and provided by the manufacturing facility.” On this news, CorMedix’s stock price fell $5.98 per share, or 39.87%, to close at $9.02 per share on March 1, 2021.

1. Author: Bragar Eagel & Squire

Category: Contact NumberShow more

DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds

6 hours ago Financialbuzz.com Show details

DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against CorMedix Inc. and Encourages Investors to Contact the Firm Posted on 09/17/2021 20857

Category: Contact NumberShow more

The Law Offices of Frank R. Cruz Reminds Investors of

3 hours ago Benzinga.com Show details

The Law Offices of Frank R. Cruz reminds investors of the upcoming September 20, 2021 deadline to file a lead plaintiff motion in the class action filed on …

Category: Contact NumberShow more

Should You Hold CorMedix Inc. (CRMD) Stock Tuesday Morning?

7 hours ago Investorsobserver.com Show details

CorMedix Inc. has a Long-Term Technical rank of 15. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 85% of the market scoring higher. In the Biotechnology industry which is number 132 by this metric, CRMD ranks better than 23% of stocks.

Category: Contact NumberShow more

CORMEDIX : REPORTS SECOND QUARTER AND SIX MONTH 2021

7 hours ago Marketscreener.com Show details

Conference Call Scheduled for Today at 4:30 p.m. Eastern Time. Berkeley Heights, NJ - August 12, 2021 - CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced financial results for the second …

Category: Contact NumberShow more

Lauren D. Human Resources Director HR Business Partner

9 hours ago Linkedin.com Show details

CorMedix, Inc. is a public development-stage pharmaceutical and medical device company that seeks to in-license, develop, and commercialize therapeutic products …

Title: HR Leader | Strategic Human …
Location: New York City Metropolitan
1. 500+ connections

Category: Contact NumberShow more

The Law Offices of Frank R. Cruz Reminds Investors of

1 hours ago Apnews.com Show details

310-914-5007

If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to the pending class action lawsuit, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 1999 Avenue of the Stars, Suite 1100, Los Angeles, California 90067 at 310-914-5007, by

Category: Contact NumberShow more

CorMedix Inc. (NASDAQ:CRMD) Share Price Recovers 8.98%

4 hours ago Marketingsentinel.com Show details

CorMedix Inc.’s shares saw a change of -35.53% in year-to-date performance and have moved 2.79% in past 5-day. CorMedix Inc. (NASDAQ:CRMD) showed a performance of -25.51% in past 30-days. Number of shares sold short was 2.58 million shares which calculate 5.8 days to cover the short interests.

Category: Contact NumberShow more

CorMedix Inc. Announces Abstracts at Upcoming Conferences

7 hours ago Finance.yahoo.com Show details

BERKELEY HEIGHTS, N.J., Oct. 20, 2021 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the

Category: Contact NumberShow more

All Time Past 24 Hours Past Week Past month

Please leave your comments here:

Popular Brands

Costco
Cisco
Ccu
Cae